Clinical Takeaway
People with PTSD and co-occurring substance use disorders who also use cannabis can still benefit meaningfully from trauma-focused treatments. Clinicians should not withhold or delay evidence-based PTSD care based on a patient’s cannabis use status.
#5 Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data.
Citation: Hill Melanie L et al.. Cannabis use and trauma-focused treatment for co-occurring posttraumatic stress disorder and substance use disorders: A meta-analysis of individual patient data.. Journal of anxiety disorders. 2024. PMID: 38266511.
Design: 6 Journal: 0 N: 4 Recency: 1 Pop: 2 Human: 1 Risk: -2
This meta-analysis provides critical evidence on whether standard trauma-focused PTSD interventions remain efficacious in the clinically common scenario of cannabis use comorbidity, addressing a significant gap in treatment guidelines for dual-diagnosis patients. The findings directly inform clinical decision-making about whether to defer evidence-based trauma treatment pending cannabis cessation or to proceed with integrated care, potentially reducing therapeutic delays in a vulnerable population. Understanding cannabis-specific treatment responses is essential for optimizing outcomes in the approximately 50-80% of individuals with PTSD who also use substances.
Quality Gate Alerts:
- Preclinical only
Abstract: High rates of cannabis use among people with posttraumatic stress disorder (PTSD) have raised questions about the efficacy of evidence-based PTSD treatments for individuals reporting cannabis use, particularly those with co-occurring alcohol or other substance use disorders (SUDs). Using a subset of four randomized clinical trials (RCTs) included in Project Harmony, an individual patient meta-analysis of 36 RCTs (total N = 4046) of treatments for co-occurring PTSD+SUD, we examined differences in trauma-focused (TF) and non-trauma-focused (non-TF) treatment outcomes for individuals who did and did not endorse baseline cannabis use (N = 410; 70% male; 33.2% endorsed cannabis use). Propensity score-weighted mixed effects modeling evaluated main and interactive effects of treatment assignment (TF versus non-TF) and baseline cannabis use (yes/no) on attendance rates and within-treatment changes in PTSD, alcohol, and non-cannabis drug use severity. Results revealed significant improvements across outcomes among participants in all conditions, with larger PTSD symptom reductions but lower attendance among individuals receiving TF versus non-TF treatment in both cannabis groups. Participants achieved similar reductions in alcohol and drug use across all conditions. TF outperformed non-TF treatments regardless of recent cannabis use, underscoring the importance of reducing barriers to accessing TF treatments for individuals reporting cannabis use.
🧠 While this meta-analysis of individual patient data from Project Harmony addresses an important clinical gap—how cannabis use affects trauma-focused treatment outcomes in people with co-occurring PTSD and substance use disorders—several limitations warrant careful interpretation. The analysis drew from only four of 36 available RCTs, potentially introducing selection bias and reducing generalizability, and the authors did not detail baseline cannabis use severity, patterns of use during treatment, or whether cannabis served primarily as self-medication for PTSD symptoms versus independent substance misuse. Confounders such as treatment engagement, motivation for change, and concurrent psychosocial support are difficult to control in secondary analysis and may substantially influence both cannabis use trajectories and PTSD symptom response. Clinically, this work suggests we should neither assume that active cannabis use automatically negates the benefit of evidence-based trauma therapies nor ignore it as clinically irrelevant, but rather assess cannabis use patterns individually, address underlying PTSD and other substance use concurrently using validated treatments,